News
-
-
-
REGULATED PRESS RELEASE
The Board of Directors sets out the terms and conditions for payment of the ordinary dividend to be proposed at the General Meeting of shareholders on 25 April 2024
Lagardère sets terms for ordinary dividend payment at upcoming General Meeting, detached on 26 April 2024 and payable from 30 April 2024. Group overview and financial details provided -
-
REGULATED PRESS RELEASE
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Lagardère SA provides monthly information on voting rights and shares. Details on capital stock, exercisable voting rights, and theoretical voting rights are included in the report -
REGULATED PRESS RELEASE
Full-year 2023 results
-
-
REGULATED PRESS RELEASE
Half-year liquidity contract statement
LAGARDERE SA, a French joint-stock company, has released its half-year liquidity contract statement in accordance with the French Financial Markets Authority's decision. The liquidity contract with BNP PARIBAS FINANCIAL MARKETS has resulted in a significant number of executions and traded volume. The detailed aggregated data for each negotiation day of the second semester 2023 is also provided in the press release. -
REGULATED PRESS RELEASE
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
This is a press release providing monthly information on the total number of voting rights and shares making up the share capital for Lagardère SA, a French joint-stock company. The press release includes specific details on the number of capital stock shares, exercisable voting rights, and theoretical voting rights as of December 31, 2023. Lagardère SA is a company with a share capital of €860,913,044.60 divided into 141,133,286 shares of €6.10 par value each, registered in Paris, France. -
REGULATED PRESS RELEASE
Yannick Bolloré joins the Board of Directors of Lagardère SA
![Accesswire](/assets/images/accesswire-inline.png)
-
APWG 2024 Cybercrime Research Conference Extends Submission Deadline to July 7
-
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
-
XS Financial Enters Into Definitive Agreement to Be Taken Private
-
TRU Engages Investor Relations Specialists HE Capital Markets
-
DuJour Media Jason Binn Celebrates Successful 12th Anniversary Cover Party with Star-Studded After-Party and Record Turnout
![EQS Group](/assets/images/eqs-group.png)
-
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
-
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
-
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
-
Meyer Burger makes significant progress in relocating its core business to the USA
-
BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
![Les Echos](/assets/images/les-echos.png)
-
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
-
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2024
-
2023/2024 Third Quarter Sales
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024. Detailed information per transaction
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024